Trastuzumab Completed Phase 3 Trials for Tumors Metastatic to Brain Treatment

Indications	Status	Purpose	Phase
DBCOND0029875 (Tumors Metastatic to Brain)	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT00820222	Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer	Trastuzumab (DB00072) Lapatinib (DB01259) Capecitabine (DB01101)